SS
NRIX icon

SBI Securities’s Nurix Therapeutics NRIX Stock Holding History

SBI Securities’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$631 Hold
26
– – ﹤0.01% 2960
2026
Q1 		$403 Sell
26
-150
-85% -$2.49K ﹤0.01% 2971
2025
Q4 		$3.34K Buy
176
+143
+433% +$2.05K ﹤0.01% 2194
2025
Q3 		$305 Buy
33
+15
+83% +$156 ﹤0.01% 3178
2025
Q2 		$205 Buy
+18
New +$195 ﹤0.01% 3295

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities's NRIX Position: Q2 2026 in Review

SBI Securities held its Nurix Therapeutics (NRIX) position steady in Q2 2026 at 26 shares worth $631. The position accounts for ﹤0.01% of the portfolio, ranked #2960.

SBI Securities first reported a position in NRIX in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.34K in Q4 2025. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • SBI Securities held 26 shares of Nurix Therapeutics worth $631 as of Q2 2026.
  • SBI Securities left its Nurix Therapeutics share count unchanged in Q2 2026.
  • Nurix Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2960 holding.
  • SBI Securities first reported a position in Nurix Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • SBI Securities's Nurix Therapeutics position peaked at $3.34K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.